BRIEF published on 10/31/2024 at 10:28, 1 year 3 months ago Le Dr Ian Gilham rejoint Novacyt en tant que directeur non exécutif Nomination Au Conseil D'administration Sciences De La Vie Novacyt Administrateur Non Exécutif Dr Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 1 year 3 months ago Nomination du Dr Ian Gilham au Conseil d'Administration de Novacyt Conseil D'administration Nomination Sciences De La Vie Novacyt Ian Gilham
BRIEF published on 10/31/2024 at 10:25, 1 year 3 months ago Appointment of Dr Ian Gilham to the Board of Directors of Novacyt Board Of Directors Life Sciences Appointment Novacyt Ian Gilham
PRESS RELEASE published on 10/31/2024 at 10:23, 1 year 3 months ago Directorate Change Novacyt appoints Dr Ian Gilham as Non-Executive Director, bringing expertise in life sciences companies to strengthen the Board Life Sciences Non-Executive Director Novacyt Dr Ian Gilham AIM-listed
PRESS RELEASE published on 10/31/2024 at 10:20, 1 year 3 months ago Changement au Conseil d’Administration Nomination du Dr Ian Gilham au poste d’administrateur non exécutif chez Novacyt. Son expertise renforcera le conseil d'administration de la société Conseil D'administration Santé Diagnostic Moléculaire Novacyt Dr Ian Gilham
BRIEF published on 10/17/2024 at 11:47, 1 year 3 months ago Certification IVDR pour le test Yourgene® de la mucoviscidose par Novacyt Dépistage Novacyt IVDR Mucoviscidose Yourgene
BRIEF published on 10/17/2024 at 11:47, 1 year 3 months ago IVDR Certification for Yourgene® Cystic Fibrosis Test by Novacyt Screening Novacyt IVDR Cystic Fibrosis Yourgene
PRESS RELEASE published on 10/17/2024 at 11:42, 1 year 3 months ago Certification IVDR obtenue pour le test de référence Yourgene® de la mucoviscidose Novacyt obtient la certification IVDR pour le test de mucoviscidose Yourgene®. Le test est conforme aux normes de qualité et de sécurité européennes, essentiel pour le dépistage de la mucoviscidose Dépistage Novacyt Mucoviscidose Yourgene Certification IVDR
BRIEF published on 10/10/2024 at 12:28, 1 year 4 months ago Novacyt ferme sa filiale IT-IS International EBITDA Fermeture Novacyt IT-IS International PCR Marché
BRIEF published on 10/10/2024 at 12:28, 1 year 4 months ago Novacyt closes its IT-IS International subsidiary EBITDA Closing Novacyt IT-IS International PCR Market
Published on 02/12/2026 at 17:00, 1 hour 57 minutes ago Diamcor Provides Update on Discharge of Security and Indebtedness, and Granting of Extension of Time to Hold the 2025 Annual General Meeting
Published on 02/12/2026 at 15:00, 3 hours 57 minutes ago Onco-Innovations Announces Amendment to Private Placement Pricing
Published on 02/12/2026 at 14:30, 4 hours 27 minutes ago MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/12/2026 at 14:30, 4 hours 27 minutes ago Loar Holdings Inc. Announces Date and Time for Fourth Quarter and Full Year 2025 Earnings Conference Call
Published on 02/12/2026 at 14:22, 4 hours 35 minutes ago Worksport Confirms Government Evaluation of Aetherlux(TM) Heat Pump for Potential Long-Term Supply Deal; Certification Accelerated
Published on 02/12/2026 at 17:45, 1 hour 12 minutes ago ENOGIA: Chiffre d’affaires de l’exercice 2025 : +57% (12,6 M€)
Published on 02/12/2026 at 17:45, 1 hour 12 minutes ago ENOGIA: FY 2025 revenue: +57% (€12.6 million)
Published on 02/12/2026 at 17:31, 1 hour 25 minutes ago R. STAHL launches development program for the future and withdraws from employer association
Published on 02/12/2026 at 17:08, 1 hour 49 minutes ago Siltronic releases its guidance for financial year 2026
Published on 02/12/2026 at 17:45, 1 hour 12 minutes ago MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY
Published on 02/12/2026 at 17:45, 1 hour 12 minutes ago Mr.Bricolage : Mise en place d'un nouveau contrat de crédit
Published on 02/12/2026 at 17:45, 1 hour 12 minutes ago Chiffre d’affaires des 9 premiers mois de l’exercice 2025/2026
